Correlation Between 23Andme Holding and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Viridian Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Viridian Therapeutics.
Diversification Opportunities for 23Andme Holding and Viridian Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Viridian is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Viridian Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Viridian Therapeutics. In addition to that, 23Andme Holding is 1.37 times more volatile than Viridian Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 2,747 in Viridian Therapeutics on September 26, 2024 and sell it today you would lose (816.00) from holding Viridian Therapeutics or give up 29.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
23Andme Holding Co vs. Viridian Therapeutics
Performance |
Timeline |
23Andme Holding |
Viridian Therapeutics |
23Andme Holding and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and Viridian Therapeutics
The main advantage of trading using opposite 23Andme Holding and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
Viridian Therapeutics vs. Fate Therapeutics | Viridian Therapeutics vs. Caribou Biosciences | Viridian Therapeutics vs. Karyopharm Therapeutics | Viridian Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |